Topotecan

ATC Code L01CE01

Topotecan

Definition

A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.

Also known as (s)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione, 9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin, Hycamptamine, TOPOTECAN, Topotecan Lactone — per NCIT

Also identified as

Indications

Disease Relation Source
Non-small cell lung carcinoma may treat MEDRT · Public domain (U.S. Government work)
Ovarian cancer may treat MEDRT · Public domain (U.S. Government work)
Small cell carcinoma may treat MEDRT · Public domain (U.S. Government work)
Small cell lung carcinoma may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Bronchi may treat a disease of this organ DERIVED · CC BY 4.0
Endocrine gland may treat a disease of this organ DERIVED · CC BY 4.0
Lungs may treat a disease of this organ DERIVED · CC BY 4.0

3 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.